Kerala Ayurveda Ltd

Kerala Ayurveda Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Kerala Ayurveda Ltd

₹ 514 -4.99%
25 Jul - close price
keralaayurveda.biz BSE: 530163
About

Incorporated in 1945, Kerala Ayurveda Ltd is engaged In Ayurvedlc services and products[1]

Key Points

Business Overview:[1]
Company manufactures Ayurveda products and deals in Ayurveda Research, Academies, Clinics, Hospitals, Ayurvedic Wellness Resorts and Services, cultivation of Ayurveda herbs, and maintaining a herbarium of medicinal plants

Website BSE
  • Market Cap ₹ 618 Cr.
  • Current Price ₹ 514
  • High / Low ₹ 625 / 250
  • Stock P/E
  • Book Value ₹ 20.9
  • Dividend Yield 0.00 %
  • ROCE -10.3 %
  • ROE -40.8 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Stock is trading at 24.6 times its book value
  • Company has low interest coverage ratio.
  • Promoter holding has decreased over last quarter: -20.8%
  • The company has delivered a poor sales growth of 6.25% over past five years.
  • Company has a low return on equity of -18.1% over last 3 years.
  • Company might be capitalizing the interest cost
  • Debtor days have increased from 90.1 to 116 days.
  • Working capital days have increased from 105 days to 186 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
12.78 16.82 15.27 15.09 15.86 17.61 17.28 17.12 15.40 18.60 19.35 19.35 17.57
11.72 14.74 14.80 14.43 14.05 17.04 16.81 16.50 16.80 19.15 18.98 30.33 23.00
Operating Profit 1.06 2.08 0.47 0.66 1.81 0.57 0.47 0.62 -1.40 -0.55 0.37 -10.98 -5.43
OPM % 8.29% 12.37% 3.08% 4.37% 11.41% 3.24% 2.72% 3.62% -9.09% -2.96% 1.91% -56.74% -30.90%
0.06 0.21 2.89 0.02 0.06 0.74 0.08 2.47 0.27 0.39 0.13 4.37 10.00
Interest 1.17 1.04 1.07 1.16 1.40 0.45 0.48 3.08 0.40 0.33 0.38 2.81 0.77
Depreciation 0.17 0.17 0.18 0.12 0.19 0.18 0.19 1.01 0.19 0.22 0.28 1.46 1.23
Profit before tax -0.22 1.08 2.11 -0.60 0.28 0.68 -0.12 -1.00 -1.72 -0.71 -0.16 -10.88 2.57
Tax % -22.73% 25.00% 25.12% -211.67% 25.00% 25.00% 116.67% -60.00% -25.00% -23.94% -50.00% 9.01% 19.84%
-0.16 0.81 1.58 0.67 0.21 0.51 -0.27 -0.39 -1.29 -0.54 -0.08 -11.86 2.07
EPS in Rs -0.15 0.77 1.50 0.63 0.20 0.48 -0.24 -0.32 -1.07 -0.45 -0.07 -9.86 1.72
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
26 28 33 40 44 46 54 43 56 63 73 73 75
23 25 28 35 38 43 51 43 48 58 68 85 91
Operating Profit 3 3 4 5 6 3 3 0 8 5 5 -13 -17
OPM % 11% 12% 12% 12% 13% 6% 6% 0% 14% 8% 7% -17% -22%
0 0 0 0 0 2 0 0 0 3 0 5 15
Interest 1 1 1 1 2 2 1 6 6 5 4 4 4
Depreciation 1 1 1 1 1 1 1 1 1 1 1 2 3
Profit before tax 1 2 2 3 3 2 1 -7 1 2 0 -13 -9
Tax % 31% 30% 31% 32% 32% 31% 28% -25% 28% -22% 163% 2%
1 1 2 2 2 1 1 -5 1 3 -0 -14 -10
EPS in Rs 0.98 1.05 1.64 2.08 2.18 1.14 0.83 -4.69 0.84 2.74 -0.22 -11.45 -8.66
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 10%
5 Years: 6%
3 Years: 9%
TTM: 11%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -695%
Stock Price CAGR
10 Years: 24%
5 Years: 51%
3 Years: 87%
1 Year: 66%
Return on Equity
10 Years: -6%
5 Years: -18%
3 Years: -18%
Last Year: -41%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 11 11 11 11 11 11 11 11 11 11 12 12
Reserves 3 3 5 4 7 3 4 -1 1 4 30 13
60 64 64 52 70 56 58 66 61 64 62 56
5 5 5 9 13 17 21 20 19 21 20 38
Total Liabilities 79 84 84 76 100 87 94 96 92 99 124 119
18 17 16 16 16 17 17 26 28 30 30 31
CWIP 0 0 0 6 9 10 12 2 2 0 0 1
Investments 11 11 11 11 11 11 11 11 11 11 11 9
50 56 57 42 63 49 53 56 50 57 82 77
Total Assets 79 84 84 76 100 87 94 96 92 99 124 119

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-0 0 2 2 -11 9 5 -1 9 9 -4 2
-2 -2 -1 -2 -2 -2 -4 -2 1 -5 -2 -6
1 3 -2 1 16 -11 0 2 -11 -2 21 -12
Net Cash Flow -1 2 0 -0 3 -4 1 -1 -1 2 15 -16

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 61 56 59 57 60 69 62 83 68 70 84 116
Inventory Days 299 283 234 369 380 327 307 238 213 200 243 176
Days Payable 103 104 58 78 123 115 151 126 122 124 115 90
Cash Conversion Cycle 257 235 236 348 318 282 218 195 159 146 213 202
Working Capital Days 75 93 93 124 251 142 94 128 58 44 85 186
ROCE % 3% 4% 5% 6% 7% 3% 4% -1% 10% 6% 5% -10%

Shareholding Pattern

Numbers in percentages

28 Recently
Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
61.52% 61.52% 61.52% 61.52% 61.52% 63.44% 58.58% 58.58% 58.58% 58.58% 58.58% 37.83%
0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03%
38.42% 38.43% 38.43% 38.44% 38.43% 36.51% 41.37% 41.39% 41.38% 41.37% 41.37% 62.12%
No. of Shareholders 8,0628,0797,9667,7807,8558,4288,5818,6559,0529,0099,0749,401

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls

  • Nov 2018
    Transcript
    Notes
    PPT